Pharmaceuticals, Biotechnology and Life Sciences
Shire said on Thursday that the European Commission (EC) has approved a label extension granting three new indications for CINRYZE® (C1 inhibitor [human]), broadening its use to children with Hereditary angiodema (HAE), a rare, genetic disorder that results in recurring attacks of edema (swelling). The body sites most commonly affected are mainly the extremities and abdomen.
The U.S. Patent and Trademark Office (USPTO) has been favorable to Ceylad for the fourth time for production of Allogenic TCR-Deficient CAR-T cells.
An ageing population, a growing generics market and liberalization of Over-The-Counter medicines make Japan an attractive destination for investments, particularly as the pharma industry undergoes legislative change, with the Government’s bid to cut healthcare expenditure.
Since the discovery of penicillin in 1948, antibiotics have emerged as a crucial class of pharmacological interventions responsible for treating several infectious conditions. In addition, antibiotics are also used for prophylactic purposes in patients who have undergone surgery, or immunocompromised patients (cancer patients undergoing chemotherapy), a market researcher ReportBuyer said in a report.
Creso Pharma’s subsidiary HempIndustries s.r.o. (HI) has received regulatory approval in the Czech Republic to sell its new product line called diCBDIUM.
The approval by the Czech Ministry of Agriculture, means that HI can …
Millennium Dental Technologies, Inc. has reached milestone today in the one-year anniversary of the world’s first and only US FDA clearance for full-mouth True Periodontal Regeneration.
Decision Resources Group (DRG) finds that Nucala’s novel mechanism of action and specific indication for eosinophilic asthma are key drivers behind the agent’s recent success in the severe asthma market.
Envigo announced on Wednesday that it will develop and internally validate five to seven ion channel In vitro tests for measuring cardiac risk potential
AstraZeneca’s trial treating relapsed ovarian cancer patients with olaparib met its primary endpoint, the company said Tuesday.
BASF, German based chemical company, has reported that it has raised prices of ethanolamines in Europe, effective immediately.